Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

On 1st February Professor Daniel Freeman (Psychiatry) and Professor David M Clark (Experimental Psychiatry) were presented with NIHR’s i4i (Invention for Innovation Award) Mental Health Challenge Award by Health Minister Lord O’Shaughnessy.  The record award (£3.9m) was received on behalf of a large multidisciplinary team led by Professor Freeman that will build on their early experimental demonstration ( that encountering feared situations in a virtual environment can substantially reduce the fears of people with paranoid psychosis and help them re-engage in everyday life. 

In the new work, the team will refine the virtual reality treatment to ensure it is appealing and easy to use. They will then test it in a large scale randomised controlled trial. If that trial confirms the clinical and cost-effectiveness of the treatment, the final phase of the work will involve careful implementation within the NHS. To achieve these goals, researchers from 5 different universities and mental health trusts are working closely together with a design team from the Royal College of Art, with an Oxford spinout company (Nowican)  and with service users led by the McPin Foundation. For more details of the work, see Daniel Freeman’s recent blog:

Similar stories

£36 Million Boost for AI Technologies to Revolutionise NHS Care

An Oxford project using artificial intelligence to develop digital triage tools for mental health clinicians (CHRONOS) is one of 38 projects support by the second wave of the NHS AI Lab's AI in Health and Care Award.

£9 million investment for health and social care research

The NIHR Applied Research Collaboration for Oxford and Thames Valley will launch in October 2019. It is one of 15 ARC's across England, each will work with local and national partners to address some of the nation’s most pressing challenges faced by the health and care system over the next 5 years, including dementia, obesity and mental health.

World’s largest autism grant will transform research landscape

The largest research grant ever given for neurodevelopmental conditions has been awarded by the Innovative Medicines Initiative to an international consortium academically led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London.